Lantus in the Treatment of Type 1 Diabetes Children
NCT00206401
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
Lantus and short acting analogs Vs NPH and short acting analogs
Sponsor
Baylor College of Medicine